Kingswood

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Diffuse large B-cell lymphoma

Running trials

• Active, not recruiting

  Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

  NCT04824092· Phase 3· Incyte Corporation· Source